# Combination Therapy of Betaseron-Prograf in Multiple Sclerosis

> **NCT00298662** · PHASE2 · UNKNOWN · sponsor: **Clinique de sclérose en plaques et neuromusculaire de l'Outaouais** · enrollment: 30 (—)

## Conditions studied

- Multiple Sclerosis

## Interventions

- **DRUG:** Interferon beta-1b and Tacrolimus

## Key facts

- **NCT ID:** NCT00298662
- **Lead sponsor:** Clinique de sclérose en plaques et neuromusculaire de l'Outaouais
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2003-02
- **Primary completion:** —
- **Final completion:** 2006-09
- **Target enrollment:** 30 (—)
- **Last updated:** 2006-03-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00298662

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00298662, "Combination Therapy of Betaseron-Prograf in Multiple Sclerosis". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00298662. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*